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Background: Although genetic or epigenetic alterations have been shown to affect the three-dimensional
organization of genomes, the utility of chromatin conformation in the classification of human disease has never
been addressed.
Results: Here, we explore whether chromatin conformation can be used to classify human leukemia. We map the
conformation of the HOXA gene cluster in a panel of cell lines with 5C chromosome conformation capture
technology, and use the data to train and test a support vector machine classifier named 3D-SP. We show that
3D-SP is able to accurately distinguish leukemias expressing MLL-fusion proteins from those expressing only
wild-type MLL, and that it can also classify leukemia subtypes according to MLL fusion partner, based solely on 5C data.
Conclusions: Our study provides the first proof-of-principle demonstration that chromatin conformation contains the
information value necessary for classification of leukemia subtypes.Background
The organization of the human genome in the nucleus is
non-random and important for proper gene expression
[1-4]. For instance, chromosomes are known to occupy
distinct regions called ‘chromosome territories’ that are an-
chored to the lamina. Gene-rich chromosomes tend to
localize at the center of the nucleus and gene-poor near
the periphery [5-9]. The co-localization of co-regulated
genes into transcription factories is another key feature of
genome organization that is thought to coordinate and/
or potentiate transcriptional responses [5-9]. Chromatin
architecture can also control transcription by promoting or
restricting physical proximity between distal control DNA
elements. As such, long-range contacts can correlate with
either activation or repression of transcription [10-12]. For
example, transcription activation at the β-globin locus as-
sociates with physical contacts between the locus control
region (LCR) and actively transcribed genes [13]. Con-
versely, insulator (CTCF)-mediated loops differentially
compartmentalize inactive genes away from enhancers at* Correspondence: blanchem@cs.mcgill.ca; josee.dostie@mcgill.ca
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unless otherwise stated.the apolipoprotein locus [14]. The relationship between
architecture and expression is also well illustrated by the
inactivation of one X chromosome in the nuclei of female
mammalian cells [15], where epigenetic silencing leads to a
condensed chromatin structure with silent genes at the
core and expressed ones looped out [16].
Given the relationship between genome architecture and
activity, it is not surprising that human disease can some-
times be attributed to defects in genome organization.
Compelling evidence for the role of three-dimensional
(3D) chromatin organization in human disease comes from
studies on laminopathies like the Emery-Dreifuss muscular
dystrophy. It was shown that this disease could originate
from mutations in a lamin protein that specifically causes
abnormal retention and silencing of muscle-specific genes
at the nuclear envelope [17]. The importance of spatial
genome organization in human disease is equally well
demonstrated in cancers where single nucleotide polymor-
phisms (SNPs) were found to create novel enhancers acting
long-range to activate distal genes through DNA looping
[18-20].
Overall, genome architecture is guided by chromatin
interactions with nuclear landmarks like the lamina, and
by intra- and inter-chromosomal contacts mediated by
chromatin-binding proteins. In addition to transcriptionral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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promoters, proteins like CTCF, SATB1, and the Cohesin
complex are thought to be master regulators of genome
organization. Protein complexes such as those contain-
ing Polycomb group proteins or the mixed lineage
leukemia (MLL) protein might be equally important in
shaping the human genome [21-23]. MLL is an H3K4
methyltransferase that is present in COMPASS-like
(complex of proteins associated with Set1) complexes
[24]. These multi-subunit complexes are very large, and
activate transcription partly by methylating H3 on Lys 4.
COMPASS-like complexes control the expression of
many genes with pivotal roles in development and differ-
entiation including homeobox family members like the
HOX genes.
The MLL gene is a common target in non-random
chromosomal translocations associated with both acute
lymphoblastic (ALL) and acute myeloid (AML) leukemia,
with over 50 different translocation partners identified so
far [25-27]. These translocations result in the production
of gain-of-function chimeras composed of an amino-
terminus MLL lacking the SET domain fused in frame
with another protein coding gene. In all cases, the result-
ing MLL fusion oncoprotein acts as a strong transcrip-
tional activator that disrupts the normal hematopoietic
differentiation program by inducing the aberrant expres-
sion of key regulators including HOX family members
[28]. In fact, dysregulation of HOX genes was reported to
be a dominant mechanism of leukemic transformation by
MLL fusions [29].
The mechanisms by which different MLL fusions acti-
vate transcription or lead to either AML or ALL are
poorly understood. However, the observation that many
translocation partners are elongation factors that co-exist
in a super elongation complex (SEC) with the fusion pro-
teins suggests that they can activate transcription at the
elongation step [30]. Interestingly, many fusion partners
of MLL bind each other to form transcription foci visible
by microscopy. Since the expression of MLL chimeras can
alter their localization and activity, these findings suggest
that MLL fusions might alter chromatin organization
[22,31,32]. Also, given that the epigenetic state of chroma-
tin and its conformation are thought to mutually affect
each other in self-enforcing structure-function feedback
loops [33], it seems likely that MLL fusions additionally
alter chromatin organization by modifying its epige-
nomic profile.
In infants, MLL is translocated in over 50% of acute leu-
kemias [34,35], whereas translocations in adults are most
often seen in patients having undergone chemotherapy
[36]. In general, the prognosis of AML patients expressing
MLL fusions is poor [37], and new classification methods
could help identify optimal treatment courses. We previ-
ously reported that terminal differentiation of the AMLTHP-1 cell line into macrophages is accompanied by tran-
scriptional repression and spatial remodeling of the HOXA
gene cluster [38]. From these results, we wondered
whether chromatin architecture, which in essence reflects
genome activity, could be used to classify leukemia types.
Here we present a study that provides a proof of concept
that chromatin conformation can be used to classify leu-
kemias. We found that when the highly relevant HOXA
region is considered, chromatin architecture has the infor-
mation value to distinguish between leukemia types and
subtypes.
Results and discussion
The HOXA gene cluster as a test locus
The HOX clusters encode transcription factors that are im-
portant for embryonic development and hematopoietic
lineage regulation [39,40]. Aberrant HOX expression is
found in various types of human cancers including lung
cancer [41], breast cancer [42], melanoma [43], and
leukemia [44]. HOXA9 and 10 for instance are oncogenes
overexpressed in various leukemia types and are direct tar-
gets of MLL fusion oncoproteins [45-47]. In mammals,
there are 39 HOX genes organized into 13 paralogue
groups and divided into four clusters named A, B, C, and
D located on different chromosomes [48,49]. The human
HOXA cluster spans over 100 kbp on chromosome 7 and
encodes 11 transcription factors (Figure 1A). To determine
whether chromatin architecture can be used to classify dis-
ease, we mapped the organization of a region containing
the HOXA cluster with the chromosome conformation
capture carbon copy (5C) technology (Figure 1B). The
5C method is a member of the so-called ‘3C technologies’
used to measure genome organization in vivo at high-
resolution [50,51]. 5C captures chromatin conformation by
converting chemically cross-linked chromatin segments
into unique ligation products, which are then detected
high-throughput using a modified version of ligation medi-
ated amplification (LMA).
Using an experimental design previously described [38] we
measured chromatin contacts throughout the HOXA cluster
region in a panel of leukemia cell lines (Figure 1C). This
panel, which is detailed in Additional file 1: Supplementary
Materials and methods, includes 20 samples expressing
MLL fusions and 10 with only the wt protein (Figure 1D,
left). The panel featured AML and ALL caused by a fusion
between MLL and the AF9 gene (MLL-AF9; AML), MLL
and the ENL gene (MLL-ENL; ALL), or expressing the
wild-type (wt) protein (Figure 1D, right). We also included
three embryonic carcinomas (EC) samples in this training
set to increase diversity. These are known to encode only
the wt MLL protein and express no HOXA genes ([52]
and Additional file 2: Table S1). The normalized 5C data
from these samples were derived as detailed in Additional
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Figure 1 Experimental design used to generate the training set for 3D-SP. (A) Linear schematic representation of the human HOXA cluster
region characterized in this study. Genes are illustrated as left-facing arrows to indicate transcription direction and highlight the 3’ to 5’ end
orientation of the cluster. The 11 paralogue groups are color-coded and identified above each gene. BglII restriction fragments of the HOXA
region characterized here are shown below and identified by numbers from left to right. (B) Diagram of the 5C technology. 5C quantitatively
measures chromatin contacts using primers that are complementary to predicted junctions in 3C libraries. Annealed 5C primers are ligated with
Taq DNA ligase and products are amplified by PCR using oligos recognizing the universal tails of 5C primers. In this study, amplification was
done using a fluorescently labeled reverse PCR primer and amplified 5C libraries were hybridized onto custom microarrays. (C) Leukemia cell
panel used to train 3D-SP. Cell lines are organized by leukemia type and MLL status. AF9; AF9 gene (ALL1-fused gene from chromosome 9), ENL;
ENL gene (eleven-nineteen-leukemia), wt; wild type, AML; acute myeloid leukemia, ALL; acute lymphoblastic leukemia, EC; embryonic carcinoma.
(D) Distribution of leukemia cell samples used to train 3D-SP. Left pie chart indicates the distribution of leukemias expressing either MLL fusions
or the wt protein (Leukemia types). Right pie chart shows the distribution of MLL types (MLL fusion types).
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sented in heatmap form in Additional file 4: Figures S2,
and show a very high degree of variability between all
samples, regardless of whether they express MLL fusions,
the wt protein are AML or ALL. When comparing the
average HOXA interaction frequencies (IFs) in leukemia
samples expressing MLL fusions to those encoding only wt
MLL, we could find marked differences in contact frequen-
cies between neighbors (heatmap diagonal) and betweendistal fragments interacting long-range (Figure 2A). For
example, we observed higher local contacts around the
HOXA3 gene in MLL fusion samples, and more long-
range interactions between the 5’ end, the middle and the
3’ end of the cluster in samples where only the wt MLL
protein is expressed (Figure 2A, right). These results indi-
cate that the HOXA chromatin conformation in leukemia
cell lines expressing MLL fusions and MLL wt might differ
sufficiently to be used for classification.
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Figure 2 The HOXA cluster conformation can be used to classify leukemia cell samples. (A) Averaged 5C interaction frequencies from
MLL-fusion leukemia cell samples (left), cells encoding only the wt MLL protein (middle), and difference between the two MLL leukemia types
(right). The data from the left panel are the average of the 5C datasets presented in Additional file 4: Figure S2A, and the middle panel contains
the averaged data from Additional file 4: Figure S2B. Normalized pair-wise interaction frequencies are color-coded according to the scale shown
on the bottom left of each heatmap. Numbers above and on the right of each heatmap identify BglII restriction fragments corresponding to the
restriction pattern shown below the HOXA diagrams. Intersecting column and row numbers identify DNA contacts. (B) Classification results of the
3D-SP trained to distinguish between samples expressing MLL fusions and the wt MLL protein. (C) Classification results of the 3D-SP trained to
distinguish between samples expressing either MLL-AF9 or MLL-ENL. For B and C, the leukemia training set shown in Figure 1C was used to train
3D-SP. Results shown are from a leave-one-out cross-validation of the 3D-SPs. The pie chart on the right of each table shows the overall accuracy
of the corresponding 3D-SP. Matthews Correlation Coefficient (MCC) = 0.64.
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Although significant differences could be observed be-
tween averaged IFs, this type of ‘direct’ measurement does
not reliably identify contacts that most consistently de-
scribe a particular leukemia type and that could be used
for classification. Indeed, average or greater IFs in a given
sample set might simply originate from the presence of a
few samples where these contacts are high. To more ro-
bustly distinguish between leukemia types, we developed a
support vector machine (SVM; [53]) classifier called ‘3D-
SP’ (3-Dimensional DNA Disease-Signature Predictor),
which uses the complete IF data from a 5C experiment as
basis for classification. We opted for an SVM since they
were previously shown to yield good accuracy classifiers
even for high-dimensional data [54].3D-SP was evaluated using leave-one-out cross-validation
on the set S of 30 samples shown in Figure 1C. Specifically,
for each sample s in S, a classifier was trained on the 29
remaining samples (S - {s}) and then used to predict the
class of s. The result of this cross-validation procedure is
then reported as one entry in the confusion matrix shown
in Figure 2B. This ensures that no predictor was trained
using the sample on which it is asked to make a prediction.
Using this approach, we found that leukemia samples
expressing either MLL fusions or the wt protein could
be classified with 83% accuracy by 3D-SP (Figure 2B).
Training 3D-SP to recognize features specific to MLL
fusion subtypes also yielded good classification results
by leave-one-out cross-validation albeit with a lower ac-
curacy of 73% (Figure 2C). These results demonstrate
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sify different leukemia types.
Identifying highly predictive chromatin contacts
We next wondered which HOXA contacts showed the
greatest difference between classes and conferred the lar-
gest amount of predictive power in the classification of leu-
kemias expressing either MLL fusions or the wt protein. By
measuring the information gain score of each pair-wise
interaction, we found that over 20 different contacts con-
tributed information that enhanced the classification per-
formance (Figure 3A; Student t-test P value <0.01). The
information gain estimates the reduction of entropy in the
classification achieved by each contact, and can therefore
be used to identify discriminatory interactions. As ex-
pected, there were much fewer contacts than those display-
ing large averaged IFs differences (compare Figures 2A and
3A). For instance, the predictor did not retain most neigh-
boring interactions, which were strong IF values that dif-
fered greatly between leukemia sets.
Interestingly, we observed a significant difference be-
tween the average IF values of informative contacts in
leukemias expressing MLL fusions compared to the wt
protein (Figure 3B). Specifically, we found that a region
downstream of HOXA13 at the cluster 5’ end preferentially
interacts with its 3’ part in wt MLL samples (Figure 3C,
fragments 31 to 35). In contrast, more contacts were ob-
served between the HOXA11 gene (fragments 26 and 27)
and the cluster, suggesting that these two regions are differ-
entially regulated in leukemias expressing MLL fusions.
This result was interesting in light of our previous report
that differentiation of THP-1 promyelomonocytic leukemia
cells into macrophages is accompanied by transcription re-
pression of 5’ end genes and the formation of long-range
contacts between the ends of the cluster [38]. Given that
MLL fusions appear to alter organization, perhaps by
modifying the chromatin at specific regions along the
cluster, this result might also provide insight on how
the fusions activate transcription. Whether DNA se-
quences at the HOXA11 and HOXA13 regions are im-
portant for the observed conformational changes is
unclear but mapping of CTCF and cohesin by ChIP-
seq shows that the two proteins bind to these regions
(Figure 3C, bottom). CTCF and cohesin are known to
form long-range interactions and it will be interesting
to see whether their association with the chromatin or
binding to each other to form loops are specifically
targeted by MLL fusions.
In a similar manner, we looked for HOXA contacts
showing the greatest informative differences between the
MLL fusion subtype classes (Figure 4). For this, we mea-
sured the information gain value of each feature for the
subtype prediction task and found 20 contacts with sig-
nificant predictive value (Student t-test P value <0.01)(Figure 4A). In contrast to the predictive features of MLL
leukemia types, the contacts distinguishing MLL-ENL
from MLL-AF9 leukemias were distributed throughout
the cluster (Figure 4B,C) and did not particularly cluster
at sites bound by CTCF and cohesin. These were generally
stronger in MLL-AF9 samples, except for 14-15 and 32-33
that were also identified as good predictors of wt MLL
samples. We do not think that stronger contacts in MLL-
AF9 can be explained simply by more expression of the
cluster in either of the sample sets since each featured
high and low expressers (Additional file 2: Table S1). Also,
transcriptional activity does not appear to be a defining
parameter in classification (see below and Additional file
5: Figure S4). Thus, we favor a model whereby different
MLL fusions lead to distinct chromatin conformations by
specifically recruiting proteins and modifying the chroma-
tin at the cluster.
De novo classification of MLL leukemia samples with 3D-SP
All the analyses with 3D-SP presented above were per-
formed using a leave-one-out cross-validation approach
and we wanted to confirm that the classifier would
generalize to new samples. To this end, we generated 5C
interaction maps for a test leukemia cell panel (Figure 5A
and Additional file 6: Figure S3), and used the 3D-SP
previously trained to distinguish between MLL wt and
fusions with the training set (Figure 1C) to classify these
data. The test leukemia set included leukemia cell lines
expressing MLL-AF6, MLL-AFX, and MLL-AF4 and a
new cell line expressing the MLL-AF9 fusion. Cell lines
encoding wt MLL included AML, ALL, and the EC cell
line NT2D1 induced with retinoic acid for 24 h. We
added this sample because although it does not express
an MLL fusion, the 3’ end genes are expressed and we
expect the cluster to adopt an open configuration [52].
We found that 3D-SP classified the test leukemia cell
lines expressing MLL fusions or wt MLL with perfect ac-
curacy. Furthermore, 3D-SP also correctly classified five
biological replicates of the MLL-AF9 expressing THP-1
samples produced in another study [55]. Even the EC
sample expressing 3’ end HOXA genes was correctly
classified suggesting transcription and opening of the
cluster were not determining parameters in the classifi-
cation by 3D-SP.
Indeed, transcription activity at the cluster did not
seem to be a deciding factor in the classification since
three of the four cell lines expressing MLL wt (HL60,
U937, MOLT-4) expressed significant levels of HOXA
genes, while one of the MLL fusion leukemia cell lines
(Karpas-45) did not express the genes at all and yet, all
were correctly classified (Additional file 2: Table S1). In
fact, we found that 5C performed much better than gene
expression when we compared SVM classification of a
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Figure 3 Distinct contact patterns identify MLL fusion from wt MLL leukemias. (A) Heatmap representation of the information gain scores
of contacts throughout the HOXA cluster. The values are color-coded according to the scale shown at the bottom of the heatmap. Numbers
on the left and right of heatmap identify BglII restriction fragments corresponding to the restriction pattern shown below the HOXA diagram.
Intersecting column and row numbers identify DNA contacts. (B) Averaged interaction frequencies of 22 contacts with high information gain
scores (IF values between MLL fusions and wt MLL are statistically different, P <0.01). Interaction frequencies in MLL fusion datasets are the
averaged values from Additional file 4: Figure S2A, and wt MLL values are from Additional file 4: Figure S2B. Error bars represent the standard error
of the mean. (C) Distribution of informative contacts for classification, and binding of CTCF and cohesin in THP-1 cells along the human HOXA
cluster region examined. The y-axis shows the number of CTCF ‘Tags per 10 millions’ obtained by ChIP-seq after normalization against input,
across the region characterized (x-axis). CTCF peaks are numbered from left to right (CTCF1 to 7). Regions forming contacts with high predictive
power are highlighted in orange.
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data (93%; Additional file 5: Figure S4B and C). Predic-
tion based on gene expression was improved when a
decision tree classifier was used instead of an SVM
(HOXA9; 86%, all HOXA; 83%) but remained slightly
lower than 5C classification with an SVM (Additional
file 5: Figure S4D). Although our data do not definitivelyshow that chromatin conformation is more robust than
gene expression, 5C data do appear to contain additional
information not present in gene expression datasets that
improve classification. Together, these results provide
the very first proof of principle that 3D chromatin
organization of the HOXA cluster can be used to classify
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Figure 4 Contacts throughout the HOXA cluster distinguish fusion subtypes. (A) The information gain scores of HOXA contacts distinguishing
MLL-AF9 from MLL-ENL leukemias are represented in heatmap form. The values are color-coded according to the scale shown at the bottom of the
heatmap. Numbers on the left and right of heatmap identify BglII restriction fragments corresponding to the restriction pattern shown below the HOXA
diagram. Intersecting column and row numbers identify DNA contacts. (B) Averaged interaction frequencies of 20 contacts with high information gain
scores (IF values between MLL fusions are statistically different, P <0.01). Interaction frequencies in MLL fusion datasets are the averaged values from
Additional file 4: Figure S2. Error bars represent the standard error of the mean. (C) Distribution of informative contacts for classification, and binding of
CTCF and cohesin in THP-1 cells along the human HOXA cluster region examined. The y-axis shows the number of CTCF ‘Tags per 10 millions’ obtained
by ChIP-seq after normalization against input, across the region characterized (x-axis). CTCF peaks are numbered from left to right (CTCF1 to 7).
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3D chromatin organization represents a type of higher-
order transcription regulation mechanism used to con-
trol gene expression in a tissue-specific manner. Here,
we provide evidence that chromatin conformation can
be used to classify leukemia samples. We found that
contacts from at least two regions along the HOXA clus-
ter significantly contribute to the classification. The first
region localizes at the 3’ end of the HOXA11 gene andforms more contacts with the cluster when MLL fusions
are expressed, while the second region lies downstream
of the HOXA13 gene and forms more contacts with the
cluster in samples encoding the wt protein. These results
suggest that these two regions are differently regulated
in leukemias expressing MLL fusions, and one would ex-
pect that proteins interacting with one or more of these
sequences would be responsible for these interactions.
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Figure 5 3D-SP correctly classifies MLL leukemia types de novo. (A) Leukemia cell panel used to test 3D-SP. Cell lines are organized by MLL
status and leukemia type. (B) Classification results of the test leukemia cell panel by the 3D-SP trained to distinguish between MLL fusion and wt
MLL (Figure 1C). Results shown are from de novo classification by the 3D-SP. Matthews Correlation Coefficient (MCC) = 1.0.
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the various leukemias in our study, and found that they
do not explain the differences in 5C. Interestingly how-
ever, we found that CTCF and cohesin are present at
these interacting sites at least in the THP-1 cell line ex-
pressing MLL-AF9. CTCF and cohesin are known chro-
matin organizers [56] and it will be interesting to see
whether differences in CTCF or cohesin binding at these
sites play a role in the classification.
In the current model of genome structure-function,
chromatin conformation and its molecular composition
are thought to mutually affect each other to reach and
propagate a given activity [33]. One argument, which
could arise, therefore is that chromatin conformation ac-
curately classifies leukemia samples because it reflects
differences in transcription. However, comparison be-
tween classification with chromatin conformation and
with gene expression suggests that at least in the case of
MLL-fusion derived leukemias, the information provided
by the chromatin organization does not simply reflect its
transcriptional state. For example, samples that express
high levels of 5’ end HOXA genes might all classify to-
gether because chromatin is likely to be more open in
that part of the cluster. We show that this is not the case
first by demonstrating that cell samples expressing dif-
ferent levels of HOXA genes classify properly in the
same groups, and secondly, by demonstrating that classifi-
cation is at least comparable or better with chromatin
conformation than gene expression. What the classifica-
tion results suggest is that as a chromatin modifier, the
MLL wt and MLL fusion proteins differently affect the
molecular composition and conformation of the chroma-
tin in a manner that is at least partly independent of its
effect on transcription activity. In turn, our results show
that chromatin organization is not merely tissue-specific
but can also differ when different diseases affect a given
cell type. Long-range transcription regulation might
therefore be specifically altered in human diseases, and
sometimes even significantly contribute to pathologies.In the future, it will be interesting to determine
whether expanding the 5C analysis to other MLL fusion
target domains can predict leukemia types and subtypes
with near-perfect accuracy. Identifying the type and sub-
type of the leukemia is the most important factor in de-
fining a treatment course, and for this reason it will also
be interesting to see whether chromatin conformation
can accurately classify samples collected from the blood
of patients, and predict overall survival. With the con-
stant improvement of deep sequencing methods and of
protocols capturing genome organization [57,58], identi-
fying bona fide chromatin conformation signatures use-
ful in the clinic is becoming increasingly feasible. The
clinical importance of biomarkers for diagnosis, therapy
selection, and for screening and monitoring disease pro-
gression is already appreciated in the treatment of many
cancer types [59]. The identification of robust bio-
markers will be important in directing patient care to-
wards a customized setting and will require a greater
overall understanding of genome regulation including
how it is organized in the nuclear space.
Materials and methods
Ethical approval
No ethical approval was needed for this study.
Cell culture and description of the 5C datasets
All experiments presented in this study were performed
using actively growing cells (log-phase) as defined by
growth curves. All cells were grown at 37°C in 5% CO2 at-
mosphere. A complete description of all the cell samples
can be found in Additional file 1: Supplementary Materials
and methods. The normalized 5C data in matrix format
are found in Additional file 7.
Quantitative real-time polymerase chain reaction (RT-qPCR)
HOXA gene expression was measured by quantitative
real-time polymerase chain reaction and is shown rela-
tive to actin. The RNeasy© Mini kit (Qiagen) was used
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the manufacturer. The samples were then treated with
DNAseI (NEB), and re-purified on Qiagen columns.
Two micrograms of the resulting total RNA was used in
each reverse transcription reaction with the Superscript®
III reverse transcriptase kit (Invitrogen™) and oligo (dT)20.
The SsoFast™ EvaGreen© Supermix (Bio-Rad) was used to
quantify the samples by RT-qPCR with a Bio-Rad CFX96™
(C1000™ series) real-time system. Quantification was per-
formed by two-fold serial dilutions of total cDNA. The
size and specificity of amplified products was verified on
agarose gels containing 0.5 μg/mL ethidium bromide and/
or by verifying the melting temperatures of PCR ampli-
cons. An AlphaImager© HP coupled to a 12-bit digital
camera and equipped with the AlphaView® image acquisi-
tion and analysis software (version 3.0; Alpha Innotech
Corporation) was used to document and analyze the gels.
All RT-qPCR primer sequences used in this study were
previously described [38], and their sequences are also
available on our website [60].
Chromosome conformation capture (3C) and 3C-carbon
copy (5C)
The chromosome conformation capture (3C) and 3C-
carbon copy (5C) techniques were used as previously de-
scribed to characterize the chromatin organization of a
region containing the HOXA gene cluster [38,51]. The ex-
perimental design and the procedure used to generate our
3C and 5C datasets are described in detail in Additional
file 1: Supplementary Materials and methods.
Interaction frequency (IF) normalization
We modified the previously published approach to nor-
malize interaction frequency data [51] to account for the
amount of DNA hybridized onto arrays (hybridization effi-
ciency) and improve correction for primer pair efficien-
cies. This approach is described in detail in Additional
file 1: Supplementary Materials and methods, and is illus-
trated in Additional file 3: Figure S1.
Support vector machine implementation
A support vector machine (SVM) classifier [53] was imple-
mented using the open-source Weka Java package [61,62].
The SVM hyperparameters (notably the soft margin pen-
alty and the RBF width) were fixed for all experiments and
the SVM used a polynomial kernel (K (x, y) = < x, y > p)
and was trained using sequential optimization minimi-
zation, with 1-vs-1 pairwise classification for multi-class
problems [63,64]. Each 5C dataset was represented as a
single vector of normalized IF values obtained by measur-
ing pairwise chromatin interactions in vivo. The SVM
was trained and evaluated using a leave-one-out cross-
validation approach to obtain a classifier with a maximum-
margin hyperplane in the transformed feature space. Thepredictive power of individual features was evaluated using
the information gain score (also computed using Weka),
which measures the reduction of the entropy of the class
distribution when the feature is considered. Contacts with
large information gains confer the highest amount of pre-
dictive power. Informative contacts were selected by deter-
mining if the IF values were statistically different between
sample types. This was done by calculating P values using
a two-sided Student’s t-Test in R [65]. The two samples
(MLL fusions vs. wt, or MLL-AF9 vs. MLL-ENL) t-test was
performed for each feature independently, and features
that were retained had reported P values below a threshold
of 0.01 (P <0.01).
The Matthews Correlation Coefficient (MCC) was cal-
culated as a measure of the quality of the classifications
performed by the SVM, with values close to +1 indicating
perfect prediction, values close to 0 indicating random
prediction, and values close to -1 indicating complete
disagreement between the prediction and the observa-
tion. The MCC statistic was calculated from the confu-
sion matrix as:
MCC ¼ TPxTNð Þ− FPxFNð Þð Þ
sqrt TPþ FPð Þ  TPþ FNð Þ  TNþ FPð Þ  TNþ FNð Þð Þ
whereTP : TruePositives;TN : TrueNegatives; FP : FalsePositives;
FN : FalseNegatives
ChIP-seq
Chromatin immunoprecipitation was conducted as de-
scribed previously [55] with 5 μL of antibodies against
CTCF (Millipore, cat. no. 07–729) or Rad21 (Abcam,
cat. no. ab992). For Rad21 samples, the BARCODE
adaptors were used for generating the BARCODE ChIP-
seq libraries (BARCODE adaptor [66]). ChIP-seq librar-
ies were sequenced with an Illumina Genome Analyzer
(GAiiX) DNA sequencer (36 bps reads, CTCF and
WCE) and Illumina Hiseq2000 (51 bps reads, Rad21) at
the Génome Québec Innovation Centre [67].
ChIP-seq data analysis
For BARCODE ChIP-seq libraries (Rad21), FASTX-
Toolkit (version 0.0.13) [68] was used to split the reads
according to the specific nucleotide barcode in first 4 bp
of sequence reads. Before mapping to the genome, the
first 4 bps barcode nucleotide of each read were
trimmed. Sequence reads with low quality in 3’ ends
were trimmed to 25 bps (one lane of sequence reads in
Rad21 samples). Sequence reads (Fastq format) were
aligned to the human genome (UCSC hg19) using the
Bowtie program [69]. One mismatch was allowed to the
unique mapped reads (option: -v 1 -m 1). Peak calling
was performed with the HOMER program [70] and
WCE data was used as control. The total mapped tags in
each sample were normalized to ‘Tags per 10 millions’
Rousseau et al. Genome Biology 2014, 15:R60 Page 10 of 12
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fold (CTCF) or four fold (Rad21) over in both control
(whole cell extract) and local region (10 kbp) were iden-
tified by HOMER program (FDR <0.001 (‘findpeak’ com-
mand)). The data was visualized in the hg19 genome
version on the UCSC browser.
Databases and URLs
The data and source code of our software are available
through our website with instructions at the following
address: [71]. The source code of our software is also at-
tached to this manuscript for archival purpose only
(Additional file 8). The 5C and ChIP-seq data for CTCF
and Rad21 can be downloaded from the Gene Expres-
sion Omnibus (GEO) website [72].
Additional files
Additional file 1: Supplementary Materials and methods,
Supplementary Figure legends, and Supplementary References. The
Supplementary Materials and methods contain a detailed description of
the cell lines analyzed in this study. It also describes the 3C and 5C
protocols used to capture chromatin organization, and the computational
approach developed to calculate normalized interaction frequencies (IFs).
This file also contains the figure legends for (Additional file 3: Figures S1,
Additional file 4: Figures S2, Additional file 5: Figures S4, and Additional file 6:
Figures S3 respectively), as well as References relevant to Additional file 1.
Additional file 2: Table S1. HOXA gene expression in leukemia cell
samples used in this study. This table contains the mRNA quantification
of all HOXA genes by RT-qPCR in cell lines used to compare classification
by gene expression and chromatin conformation (Additional file 5: Figure S4).
Additional file 3: Figure S1. Workflow of 5C data processing,
normalization, and conversion into interaction frequencies. This figure
illustrates our approach to calculate normalized IFs from 5C data. This
method and Additional file 3: Figure S1 are described in detail in
(Additional file 1: Supplementary Materials and methods and Additional
file 3: Figure S1).
Additional file 4: Figure S2. 5C datasets generated for the 3D-SP
training set. This figure shows the 5C data of the cell samples from the
training set in the form of heatmaps as described in Additional file 4:
Figure S2 (Additional file 1).
Additional file 5: Figure S4. 3D-SP performs better than gene
expression to classify MLL leukemia types. This figure compares
classification of leukemia cell samples using HOXA gene expression and
HOXA chromatin organization. The figure is described in the Additional
file 5: Figure S4 in Additional file 1.
Additional file 6: Figure S3. 5C datasets generated for the 3D-SP test set.
This figure shows the 5C data of the cell samples from the test set in the form
of heatmaps as described in Additional file 6: Figure S3 (Additional file 1).
Additional file 7: This file contains the normalized 5C data in
matrix format of all the samples produced for this study. These files
can be uploaded directly in the my5C platform (http://my5c.umassmed.
edu/welcome/welcome.php) [73].
Additional file 8: This file contains the source code for all the
software used in this study.
Abbreviations
3C: Chromosome conformation capture; 5C: 3C-carbon-copy; SVM: Support
vector machine.
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